From: Looking forward to new targeted treatments for chronic spontaneous urticaria
Study drug | Type of the drug | Clinicaltrials.gov identifier | Status |
---|---|---|---|
Quilizumab | Anti-IgE | NCT01987947 | Completed |
Ligelizumab | Anti-IgE | NCT02477332 | Recruitment closed |
AZD1981 | PGD2 receptor antagonists | NCT02031679 | Data processing |
GSK2646264 | Syk inhibitor | NCT02424799 | Recruiting |
Canakinumab | Anti-IL-1 | NCT01635127 | Unknown |
Rilonacept | Anti-IL-1 | NCT02171416 | Recruiting |